Home/Filings/4/0001209191-12-008301
4//SEC Filing

Baker Joffre 4

Accession 0001209191-12-008301

CIK 0001131324other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 7:08 PM ET

Size

8.8 KB

Accession

0001209191-12-008301

Insider Transaction Report

Form 4
Period: 2012-02-05
Baker Joffre
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2012-02-05+2,000133,475 total
  • Award

    Employee Stock Option (right to buy)

    2012-02-05+18,00018,000 total
    Exercise: $29.34Exp: 2022-02-05Common Stock (18,000 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    66,343
  • Common Stock

    (indirect: By Trust)
    36,113
Footnotes (3)
  • [F1]Restricted stock units awarded on February 5, 2012, which vest as to 1/3 of the shares on February 15, 2013, 1/3 of the shares on February 15, 2014, and 1/3 of the shares on February 15, 2015.
  • [F2]Includes 4,500 restricted stock units awarded January 27, 2011 which vest as to 1/3 of the shares on February 15, 2012, 1/3 of the shares on February 15, 2013 and 1/3 of the shares on February 15, 2014.
  • [F3]The option became exercisable as to 25% of the shares on February 5, 2012, and became exercisable as to 1/48th of the shares each full month thereafter.

Issuer

GENOMIC HEALTH INC

CIK 0001131324

Entity typeother

Related Parties

1
  • filerCIK 0001337335

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 7:08 PM ET
Size
8.8 KB